Trials / Completed
CompletedNCT01051024
Diamel in the Treatment of Polycystic Ovary Syndrome
Efficacy of Diamel in the Treatment of Polycystic Ovary Syndrome
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 110 (actual)
- Sponsor
- Catalysis SL · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to assess the efficacy of Diamel administration in the treatment of Polycystic Ovary Syndrome. The duration of this double-blind placebo controlled phase 3 clinical trial will be 24 weeks.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Diamel | Two Diamel tablets (Orally administered) three times a day (just before each meal: breakfast, lunch and dinner), for 24 weeks. |
| DIETARY_SUPPLEMENT | Placebo | Two Placebo tablets (Orally administered) three times a day (just before each meal: breakfast, lunch and dinner), for 24 weeks. |
Timeline
- Start date
- 2009-11-01
- Primary completion
- 2011-04-01
- Completion
- 2011-04-01
- First posted
- 2010-01-18
- Last updated
- 2012-05-04
Locations
1 site across 1 country: Cuba
Source: ClinicalTrials.gov record NCT01051024. Inclusion in this directory is not an endorsement.